Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

16.96
+0.63003.86%
Post-market: 16.960.00000.00%19:07 EST
Volume:1.05M
Turnover:17.49M
Market Cap:2.24B
PE:-11.14
High:17.10
Open:16.49
Low:16.10
Close:16.33
Loading ...

Company Profile

Company Name:
Centessa Pharmaceuticals plc
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
75
Office Location:
1 Ashley Road,3rd Floor,Altrincham,Cheshire,United Kingdom
Zip Code:
WA14 2DT
Phone:
- -
Fax:
- -
Introduction:
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Directors

Name
Position
Antoine Yver
Executive Vice President and Chairman of Development
Francesco De Rubertis
Non-Executive Director and Chairman of the Board
Saurabh Saha
Chief Executive Officer and Director
Arjun Goyal
Non-Executive Director
Brett Zbar
Non-Executive Director
Carol Stuckley
Non-Executive Director
Mary Lynne Hedley
Non-Executive Director
Mathias Hukkelhoven
Non-Executive Director
Samarth Kulkarni
Non-Executive Director

Shareholders

Name
Position
Saurabh Saha
Chief Executive Officer and Director
Gregory Weinhoff
Chief Financial Officer
David Chao
Chief Administrative Officer
David Grainger
Chief Innovation Officer
Iqbal Hussain
General Counsel and Chief Compliance Officer
Karen Anderson
Chief People Officer
Tia Bush
Chief Quality Officer